MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus

References

• Talaat RM, Mohamed SF, Bassyouni IH, et al. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine. 2015;72(2):146–153.
   PubMed Web of Science ®Google Scholar
• Wakeland EK, Liu K, Graham RR, et al. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 2001;15(3):397–408.
   PubMed Web of Science ®Google Scholar
• Liu L, Liu Y, Yuan M, et al. Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus. Biochem Biophys Res Commun. 2017;492(3):453–460.
   PubMed Web of Science ®Google Scholar
• Cho KA, Lee JK, Kim YH, et al. Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner. Cell Mol Immunol. 2017;14(11):895–908.
   Web of Science ®Google Scholar
• Wang Q, Xu C, Zhao Y, et al. miR-26b-3p Regulates human umbilical cord-derived mesenchymal stem cell proliferation by targeting estrogen receptor. Stem Cells Dev. 2016;25(5):415–426.
   PubMed Web of Science ®Google Scholar
• Xu J, Chen J, Li W, et al. Additive therapeutic effects of mesenchymal stem cells and il-37 for systemic lupus erythematosus. JASN. 2020;31(1):54–65.
   Web of Science ®Google Scholar
• Dorraji SE, Hovd AK, Kanapathippillai P, et al. Mesenchymal stem cells and T cells in the formation of tertiary lymphoid structures in lupus nephritis. Sci Rep. 2018;8(1):7861.
   PubMedGoogle Scholar
• Xu J. Therapeutic applications of mesenchymal stem cells for systemic lupus erythematosus. Adv Exp Med Biol. 2018;1089:73–85.
   PubMed Web of Science ®Google Scholar
• Wu X, Kang H, Liu X, et al. Serum and xeno-free, chemically defined, no-plate-coating-based culture system for mesenchymal stromal cells from the umbilical cord. Cell Prolif. 2016;49(5):579–588.
   PubMed Web of Science ®Google Scholar
• Batsali AK, Kastrinaki MC, Papadaki HA, et al. Mesenchymal stem cells derived from Wharton’s Jelly of the umbilical cord: biological properties and emerging clinical applications. CSCR. 2013;8(2):144–155.
   Google Scholar
• Wang D, Wang S, Huang S, et al. Serum IFN-gamma predicts the therapeutic effect of mesenchymal stem cells transplantation in systemic lupus erythematosus patients. Stem Cells Transl Med. 2017;6(9):1777–1785.
   PubMed Web of Science ®Google Scholar
• Ruan GP, Yao X, Yang SJ, et al. Transplanted human umbilical cord mesenchymal stem cells facilitate lesion repair in B6.Fas mice. J Immunol Res. 2014;2014:1–13.
   Google Scholar
• Chen S, Chen X, Xiu YL, et al. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression. Cancer Lett. 2015;362(1):122–130.
   PubMed Web of Science ®Google Scholar
• Xin Q, Li J, Dang J, et al. miR-155 Deficiency ameliorates autoimmune inflammation of systemic lupus erythematosus by targeting S1pr1 in Faslpr/lpr Mice. JI. 2015;194(11):5437–5445. Jun 1
   Google Scholar
• Geng L, Tang X, Zhou K, et al. MicroRNA-663 induces immune dysregulation by inhibiting TGF-beta1 production in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Cell Mol Immunol. 2019;16(3):260–274.
   PubMed Web of Science ®Google Scholar
• Huang Q, Xia J, Wang L, et al. miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol. 2018;11(1):58.
   PubMedGoogle Scholar
• Ou ZL, Luo Z, Wei W, et al. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis. RNA Biol. 2019;16(11):1592–1603.
   PubMed Web of Science ®Google Scholar
• Li D, Lu Z, Li X, et al. Human umbilical cord mesenchymal stem cells facilitate the up-regulation of miR-153-3p, whereby attenuating MGO-induced peritoneal fibrosis in rats. J Cell Mol Med. 2018;22(7):3452–3463.
   PubMed Web of Science ®Google Scholar
• Navarro-Quiroz E, Pacheco-Lugo L, Navarro-Quiroz R, et al. Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis. PloS One. 2017;12(11):e0187973.
   PubMed Web of Science ®Google Scholar
• Gu Z, Akiyama K, Ma X, et al. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus. 2010;19(13):1502–1514.
   PubMed Web of Science ®Google Scholar
• Lu Z, Ye D, Qian L, et al. Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica. CNR. 2012;9(4):250–255.
   Google Scholar
• Sjostrand M, Johansson A, Aqrawi L, et al. The expression of BAFF is controlled by IRF transcription factors. J Immunol. 2016;196(1):91–96.
   PubMed Web of Science ®Google Scholar
• Mok CC, Birmingham DJ, Ho LY, et al. High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus. Arthritis Care Res. 2013;65(3):441–447.
   Web of Science ®Google Scholar
• Hsu WT, Suen JL, Chiang BL. The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol. 2006;145(3):513–519.
   PubMed Web of Science ®Google Scholar
• Ikebe C, Suzuki K. Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols. BioMed Res Int. 2014;2014:1–11.
   Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22(1):531–562.
   PubMed Web of Science ®Google Scholar
• Valencia X, Yarboro C, Illei G, et al. Deficient CD4 + CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol. 2007;178(4):2579–2588.
   PubMed Web of Science ®Google Scholar
• Bonelli M, von Dalwigk K, Savitskaya A, et al. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann Rheumat Dis. 2007;67(5):664–671.
   PubMed Web of Science ®Google Scholar
• Lin SC, Chen KH, Lin CH, Kuo CC, et al. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest. 2007;37(12):987–996.
   PubMed Web of Science ®Google Scholar
• Xiao F, Lin X, Tian J, et al. Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjogren’s syndrome. Cell Mol Immunol. 2017;14(11):924–934.
   Web of Science ®Google Scholar
• Schauvliege R, Janssens S, Beyaert R. Pellino proteins: novel players in TLR and IL-1R signalling. J Cellular Mol Med. 2007;11(3):453–461.
   PubMed Web of Science ®Google Scholar
• Chang M, Jin W, Chang JH, et al. The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity. Nat Immunol. 2011;12(10):1002–1009.
   PubMed Web of Science ®Google Scholar
• Chen FR, Zhai ZF, Shi XW, et al. Association of PELI1 polymorphisms in systemic lupus erythematosus susceptibility in a Chinese population. Lupus. 2015;24(10):1037–1044.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang X, Hao S, et al. Peli1 negatively regulates noncanonical NF-kappaB signaling to restrain systemic lupus erythematosus. Nat Commun. 2018;9(1):1136.
   PubMedGoogle Scholar